Critical Aspects of Antibody-Drug Conjugates: Structural Characterization and Analysis - - BioPharm International

ADVERTISEMENT
Critical Aspects of Antibody-Drug Conjugates: Structural Characterization and Analysis
Sep 10, 2012

 

Robert J. Duff, Ph.D.
Manager, Biopharmaceutical Services
Lancaster Laboratories

Lieza M. Danan-Leon, Ph.D.
Principal Scientist, Biochemistry
Lancaster Laboratories



During this podcast, we will discuss delivering targeted therapeutic agents with greater selectivity and less toxic side effects.

ONLINE RESOURCES
blog comments powered by Disqus
Rate this page
Would you recommend this page to a friend?
Your original vote has been tallied and is included in the ratings results.
View our top pages
Average rating for this page is: 2

ADVERTISEMENT
Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT
Author Guidelines
FindPharma
Featured Jobs

More Jobs
9/10/2012
 Click here